Not Logged In     Login  
 Release 22.0, Sept. 2008
 
Chapter : ch25. Antibiotics, Vaccines & Prophylaxis Section : Interpretation of Antibiotic Susceptibility Testing
  Minimum Lethal Concentration (MLC) of Metronidazole for Trichomonas vaginalis

  Online Excel Reference
Copyright (c) 2008-2010, Institute for Algorithmic Medicine, Houston, TX, USA. All rights reserved.

Overview :

Trichomonas vaginalis may be resistant to metronidazole therapy. The in vitro susceptibility of Trichomonas to metronidazole can be measured by the minimum lethal concentration (MLC).

 

Medium: Diamond's medium

 

Antibiotic: metronidazole

 

Antibiotic concentrations (serial dilutions of 200 µg/mL concentration):

(1) 0.75 µg/mL

(2) 1.5 µg/mL

(3) 3.1 µg/mL

(4) 6.2 µg/mL

(5) 12.5 µg/mL

(6) 25 µg/mL

(7) 50 µg/mL

(8) 100 µg/mL

(9) 200 µg/mL

 

Control: ATCC strain 30001 with MLC 0.5 µg/mL

 

The cultures are examined for motile trichomonads at 24 and 48 hours.

 

Interpretation:

• The minimum lethal concentration is that with no motile trichomonads seen at 48 hours.

• The higher the MLC the more likely that oral metronidazole therapy will be ineffective.

 

  References:

Meingassner JG, Mieth H, et al. Assay conditions and the demonstration of nitroimidazole resistance in Trichomonas foetus. Antimicrob Agents Chemother. 1978; 13: 1-3.

Muller M, Lossick JG, Gorrell TE. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis. 1988; 15: 17-24.

Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis. 2001; 33: 1341-1346.

 

 

   Online Excel | Reference TOP
     Pubmed Search For
Copy and paste the article title, or authors names into the search box